Salta al menu principale di navigazione Salta al contenuto principale Salta al piè di pagina del sito
FrancoAngeli Journals

Editoriale

N. 55 (2024)

Editoriale

DOI
https://doi.org/10.3280/qpc55-2024oa20369
Inviata
12 giugno 2025
Pubblicato
08-07-2025

Riferimenti bibliografici

  1. Abikoff H., Hechtman L., Klein R.G., Weiss G., Fleiss K., Etcovitch J., Cousins L., Greenfield B., Martin D. & Pollack S. (2004). Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 43(7): 802-811. DOI: 10.1097/01.chi.0000128791.10014.ac.
  2. Banaschewski T., Häge A., Hohmann S. & Mechler K. (2024). Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use. Frontiers in psychiatry, 14, 1289157. DOI: 10.3389/fpsyt.2023.1289157.
  3. Bowman E., Coghill D., Murawski C. & Bossaerts P. (2023). Not so smart? “Smart” drugs increase the level but decrease the quality of cognitive effort. Science advances, 9(24), eadd4165. DOI: 10.1126/sciadv.add4165.
  4. Chan A.Y.L., Ma T.T., Lau W.C.Y., Ip P., Coghill D., Gao L., Jani Y.H., Hsia Y., Wei L., Taxis K., Simonoff E., Taylor D., Lum T.Y., Man K.K.C. & Wong I.C.K. (2023). Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study. EClinicalMedicine, 58, 101780. DOI: 10.1016/j.eclinm.2022.101780.
  5. Cortese S., Adamo N., Del Giovane C., Mohr-Jensen C., Hayes A.J., Carucci S., Atkinson L.Z., Tessari L., Banaschewski T., Coghill D., Hollis C., Simonoff E., Zuddas A., Barbui C., Purgato M., Steinhausen H.C., Shokraneh F., Xia J. & Cipriani A. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet, Psychiatry, 5(9): 727-738. DOI: 10.1016/S2215-0366(18)30269-4.
  6. Cortese S., Ferrin M., Brandeis D., Buitelaar J., Daley D., Dittmann R.W., Holtmann M., Santosh P., Stevenson J., Stringaris A., Zuddas A., Sonuga-Barke E.J. & European ADHD Guidelines Group (EAGG) (2015). Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. Journal of the American Academy of Child and Adolescent Psychiatry, 54(3): 164-174. DOI: 10.1016/j.jaac.2014.12.010.
  7. Daley D., van der Oord S., Ferrin M., Danckaerts M., Doepfner M., Cortese S., Sonuga-Barke E.J. & European ADHD Guidelines Group (2014). Behavioral interventions in attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials across multiple outcome domains. Journal of the American Academy of Child and Adolescent Psychiatry, 53(8): 835-847, e8475. DOI: 10.1016/j.jaac.2014.05.013.
  8. Dekkers T.J. (2024). Commentary: Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use. Frontiers in psychiatry, 15, 1383492. DOI: 10.3389/fpsyt.2024.1383492.
  9. Faraone S.V., Banaschewski T., Coghill D., Zheng Y., Biederman J., Bellgrove M.A., Newcorn J.H., Gignac M., Al Saud N.M., Manor I., Rohde L.A., Yang L., Cortese S., Almagor D., Stein M.A., Albatti T.H., Aljoudi H.F., Alqahtani M.M.J., Asherson P., Atwoli L., … Wang Y. (2021). The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neuroscience and biobehavioral reviews, 128: 789-818. DOI: 10.1016/j.neubiorev.2021.01.022.
  10. Hornborg C., Axrud R., Vicente R.P. & Merlo J. (2023). Socioeconomic disparities in attention deficit hyperactivity disorder (ADHD) in Sweden: An intersectional ecological niches analysis of individual heterogeneity and discriminatory accuracy (IEN-AIHDA). PLoS One, 18(11), e0294741. DOI: 10.1371/journal.pone.0294741.
  11. ISTAT (2024). Report “L’inclusione scolastica degli alunni con disabilità, 2022-2023”. Disponibile su: www.istat.it/wp-content/uploads/2025/03/Alunni-con-disabilita-as-23-24.pdf.
  12. Kazda L., Bell K., Thomas R., McGeechan K., Sims R. & Barratt A. (2021). Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review. JAMA network open, 4(4), e215335. DOI: 10.1001/jamanetworkopen.2021.5335.
  13. Polanczyk G.V., Salum G.A., Sugaya L.S., Caye A. & Rohde L.A. (2015). Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. Journal of child psychology and psychiatry, and allied disciplines, 56(3): 345-365. DOI: 10.1111/jcpp.12381.
  14. Sonouga-Barke E.J.S. (2024). Relazione al Congresso EUNETHYDIS, Cagliari 7 ottobre 2024, (non pubblicata).
  15. Sonuga-Barke E.J., Brandeis D., Cortese S., Daley D., Ferrin M., Holtmann M., Stevenson J., Danckaerts M., van der Oord S., Döpfner M., Dittmann R.W., Simonoff E., Zuddas A., Banaschewski T., Buitelaar J., Coghill D., Hollis C., Konofal E., Lecendreux M., Wong I.C., … European ADHD Guidelines Group (2013). Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. The American journal of psychiatry, 170(3): 275-289. DOI: 10.1176/appi.ajp.2012.12070991.
  16. Sonuga-Barke E.J.S., Becker S.P., Bölte S., Castellanos F.X., Franke B., Newcorn J.H., Nigg J.T., Rohde L.A. & Simonoff E. (2023). Annual Research Review: Perspectives on progress in ADHD science – from characterization to cause. Journal of child psychology and psychiatry, and allied disciplines, 64(4): 506-532.DOI: 10.1111/jcpp.13696.
  17. Storebø O.J., Storm M.R.O., Pereira Ribeiro J., Skoog M., Groth C., Callesen H.E., Schaug J.P., Darling Rasmussen P., Huus C.L., Zwi M., Kirubakaran R., Simonsen E. & Gluud C. (2023). Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). The Cochrane database of systematic reviews, 3(3): CD009885. DOI: 10.1002/14651858.CD009885.pub3.
  18. Storebø O.J., Ramstad E., Krogh H.B., Nilausen T.D., Skoog M., Holmskov M., Rosendal S., Groth C., Magnusson F.L., Moreira-Maia C.R., Gillies D., Buch Rasmussen K., Gauci D., Zwi M., Kirubakaran R., Forsbøl B., Simonsen E. & Gluud C. (2015). Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database of Systematic Reviews, (11), CD009885. DOI: 10.1002/14651858.CD009885.pub2.
  19. Swanson J.M. (2019). Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long Term? (Against). Journal of the American Academy of Child and Adolescent Psychiatry, 58(10): 936-938. DOI: 10.1016/j.jaac.2019.07.001.
  20. Swanson J.M., Rommelse N., Cotton J., Sonuga-Barke E.J.S., Jensen P.S. & Castellanos F.X. (2022). Attention-Deficit Hyperactivity Disorder. In: Pfaff D.W., Volkow N.D. & Rubenstein J.L. (eds.), Neuroscience in the 21st Century. Cham: Springer.
  21. Te Meerman S., Freedman J.E. & Batstra L. (2022). ADHD and reification: Four ways a psychiatric construct is portrayed as a disease. Frontiers in psychiatry, 13, 1055328. DOI: 10.3389/fpsyt.2022.1055328.
  22. Willcutt E.G. (2012). The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics, 9(3): 490-499. DOI: 10.1007/s13311-012-0135-8.

Metriche

Caricamento metriche ...